WuXi AppTec USA

WuXi AppTec USA is owned by HiberCell. HiberCell has a direct presence in 2 countries.

HiberCell has 7 subsidiaries including Genuity Science, WuXi Advanced Therapies and WuXi AppTec.

View the org chart displaying its 4 main executives

Most searched biographies at WuXi AppTec USA

• Rj Fitch, Vice President, Operations and General Manager
• Ronald Aldridge, Director of Investor Relations
• Richard Connell, Senior Vice President and Chief Operating Officer

Create your alert
to follow the executive moves at WuXi AppTec USA.

HiberCell has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by WuXi AppTec USA

Social media about WuXi AppTec USA

• WuXi AppTec USA on Wikipedia, Google News & Yahoo Finance
• WuXi AppTec USA on LinkedIn, Twitter & YouTube

Contact by email its executives including Rj Fitch

Call WuXi AppTec USA at +1 651...

View the org chart

Register to receive your alert

Report an error